PLSE - Pulse Biosciences, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$30.00
DETAILS
HIGH:
$30.00
LOW:
$30.00
MEDIAN:
$30.00
CONSENSUS:
$30.00
UPSIDE:
15.87%
About Pulse Biosciences, Inc. (https://www.pulsebiosciences.com)
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Darrin R. Uecker | Chief Technology Officer & Director | 1966 | $869,889 USD |
| Paul Arthur LaViolette | President, Chief Executive Officer & Co-Chairman of the Board | 1958 | $765,068 USD |
| Mitchell E. Levinson | Chief Strategy Officer | 1960 | $584,565 USD |
| Jon Skinner | Chief Financial Officer | 1986 | $459,898 USD |
| David Danitz | Senior Vice President of Engineering | – | – |
| David Kenigsberg | Chief Medical Officer | – | – |
| Edison Manuel | Vice President of Operations | – | – |
| Gansevoort Dunnington | Chief Medical Officer | – | – |
| Kenneth Stratton | General Counsel & Corporate Secretary | 1969 | – |
| Liane Teplitsky | Chief Operating Officer | 1977 | – |
| Niv Ad | Chief Science Officer of Cardiac Surgery | – | – |
| Patty Perla | Vice President of Human Resources | – | – |
| Steven T. Weber | Vice President of Accounting, Principal Accounting Officer & Global Corporate Controller | 1976 | – |